Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, announced on 4/4/2018 the... read more
Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, announced on 4/4/2018 the... read more
ITBMed announces the completion of an equity investment of up to $67 million, led by Pablo Legorreta, the founder and CEO of Royalty Pharma. This capital injection will be used to develop... read more
Versant Ventures today announced that Roche Holdings Inc. has acquired the Inception 5 program, focused on regenerative therapies for multiple sclerosis.
The acquisition is the culmination... read more
On 4/3/2018, Denovo Biopharma LLC, announced dosing of the first patient in its pivotal Phase 3 ENGINE trial. The ENGINE trial is a global, randomized, double-blind, registrational study... read more
